The CURE SYNGAP1 Sponsorship Prospectus offers a strategic gateway for industry and medical partners to engage with a leading Patient Advocacy Group (PAG). As an organization dedicated to curing the ultra-rare genetic disorder SYNGAP1, our focus is centered on accelerating the transition from laboratory discovery to clinical application.
Sponsorship provides your organization with premium visibility among biopharma executives, clinicians, and rare disease advocates at the forefront of genetic medicine. By partnering with CURE SYNGAP1, you are investing in the data, community, and infrastructure necessary to make a cure a reality. Together, we can ensure that industry leaders and scientific partners de-risk the development of SYNGAP1 therapies and bring life-changing treatments to our global patient population.
View our full 2026 Prospectus below.
If you are interested in partnering with CURE SYNGAP1 or have questions, please email us: Sponsor@cureSYNGAP1.org.
CURE SYNGAP1 2026 PROSPECTUS by Suzanne Jones
Download the pdf here.